menu
    • menu

    Company profile for Exousia Pro

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Exousia Pro is a clinical-stage biotech pioneering exosome-based therapies to revolutionize oncology treatment. Leveraging the natural therapeutic potential of exosomes, we develop targeted, innovative solutions to combat cancer with enhanced precision and reduced side effects. Our cutting-edge research harnesses exosomes' unique properties for drug delivery, immune modulation, and diagnostics. Committed to transforming patien...
    Exousia Pro is a clinical-stage biotech pioneering exosome-based therapies to revolutionize oncology treatment. Leveraging the natural therapeutic potential of exosomes, we develop targeted, innovative solutions to combat cancer with enhanced precision and reduced side effects. Our cutting-edge research harnesses exosomes' unique properties for drug delivery, immune modulation, and diagnostics. Committed to transforming patient outcomes, we bridge groundbreaking science with clinical applications to unlock new frontiers in cancer therapy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Exousia ProUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    7901 4th Street N #23494 St. Petersburg, FL 33702
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://exousiapro.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nextel Medical Corp Reaches Key Phase In NANOG DNA Cancer Test
    Nextel Medical Corp Reaches Key Phase In NANOG DNA Cancer Test

    07 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/07/3269397/0/en/NexTel-Medical-Corp-Announces-Pivotal-Milestone-in-Commercial-Launch-of-Patent-Protected-NANOG-DNA-Cancer-Screening-Test.html

    GLOBENEWSWIRE
    07 Apr 2026
    Share Share
    Exousia Pro Settles Litigation, Eliminates Debt, Cancels Shares
    Exousia Pro Settles Litigation, Eliminates Debt, Cancels Shares

    16 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/16/3256422/0/en/Exousia-Pro-Inc-Announces-Favorable-Litigation-Settlement-Highlighting-Significant-Debt-Elimination-and-Share-Cancellation-to-Enhance-Shareholder-Value.html

    GLOBENEWSWIRE
    16 Mar 2026
    Share Share
    Exousia Pro Halts 47M Share Issuance, Boosts Telehealth
    Exousia Pro Halts 47M Share Issuance, Boosts Telehealth

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3250550/0/en/Exousia-Pro-Inc-Announces-Strategic-Elimination-of-Future-Dilutive-Issuance-of-47-Million-Shares-Progresses-Toward-Definitive-Agreements-for-Telehealth-Acquisitions.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    Exousia Pro Expands via Third Telehealth Acquisition
    Exousia Pro Expands via Third Telehealth Acquisition

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235529/0/en/Exousia-Pro-Inc-Accelerates-Strategic-Expansion-with-Third-Telehealth-Acquisition-Strengthens-Pathway-to-Low-Cost-Customer-Acquisition.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    Exousia Signs Strategic LOI for Nutraceutical Commercialization
    Exousia Signs Strategic LOI for Nutraceutical Commercialization

    11 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-11/exousia-pro-inc-announces-executed-loi-for-strategic-acquisition-of-high-revenue-telehealth-platfo

    PHARMIWEB
    11 Dec 2025
    Share Share
    Exousia Pro Revolutionizes Nutraceuticals With Launch Of Maxasome
    Exousia Pro Revolutionizes Nutraceuticals With Launch Of Maxasome

    05 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-05/exousia-pro-inc-revolutionizes-nutraceuticals-with-launch-of-maxasome-tm-the-first-all-natural

    PHARMIWEB
    05 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search